abstract |
(57) [Problem] To provide a novel influenza DNA vaccine which can impart high immunity to influenza virus, particularly an influenza DNA vaccine which can be transdermally administered. An influenza vaccine comprising a DNA having a base sequence encoding a matrix protein of an influenza virus or an antigenic epitope thereof. |